The Venture Codex

Participated · Series F · Jun 2026

Baseten provides software and multi-cloud compute infrastructure to help companies optimize, customize, and serve open-source AI models, handling inference workloads and latency optimization. The company positions itself as enabling enterprises to deploy open-source models efficiently, competing with closed-source alternatives by reducing costs; at least one customer reported up to a 30% cost reduction. Key customers include Cursor, Mercor, and OpenEvidence. Baseten’s annualized revenue run rate has surged from roughly $200 million to about $600 million. The company has rapidly increased its valuation in 2025–2026 through multiple financing rounds, most recently reaching as high as $13 billion in the current transaction.

Participated · Equity · Feb 2026

Founded in 2021, Honest Health partners with hospitals and provider groups to navigate value-based, risk-bearing reimbursement models. Its platform supplies clinicians with actionable analytics, operational support, and shared-accountability structures that prioritize quality and cost containment over volume. Led by CEO Rob Bessler, M.D., and backed by founders from Rubicon Founders, the company combines deep clinical expertise with scalable technology infrastructure. Honest Health’s services include care coordination tools and performance dashboards designed to improve patient outcomes and financial performance for health systems. The company has rapidly gained traction, prompting sizable investor interest. Proceeds from its latest funding will be used to expand into additional U.S. markets, form new partnerships with payers and providers, and further develop its technology and service offerings. No revenue or user metrics were disclosed in the article, but management cites “measurable improvements” in outcomes and cost savings as evidence of early success.

Participated · Series C · Feb 2026

Founded in 2016, Skyryse is an El Segundo, California–based aviation automation company focused on SkyOS, a flight control operating system that replaces dozens of traditional gauges and switches with touchscreen-based automation. The system handles take-off, landing, hover, and engine-out emergencies, while still keeping a pilot in the loop, thereby enhancing safety and reducing pilot workload. Skyryse has already integrated SkyOS into platforms ranging from civilian helicopters to U.S. military Black Hawk helicopters and has inked integration contracts with United Rotorcraft, Air Methods, and Mitsubishi Corporation. The company is nearing the final stages of FAA certification after receiving final design approval for its flight control computers. New funding will accelerate SkyOS deployment across additional aircraft types and support the remaining certification testing. Including the latest round, Skyryse has secured more than $605 million in equity financing and now carries a $1.15 billion valuation.

Participated · Series D · Jan 2026

Founded six years ago in Berlin, Parloa builds conversational AI agents that handle customer calls and messages for large enterprises such as Allianz, Booking.com, HealthEquity, SAP, Sedgwick, and Swiss Life. Its platform aims to replace human contact-center work by providing contextual, personalized service that can identify a caller and address their needs across phone, web, and app touchpoints. The company disclosed annual recurring revenue of more than $50 million as of last month, positioning it alongside leading peers in the rapidly growing customer-service automation market that Gartner estimates employs 17 million agents worldwide. Management plans to devote substantial new capital to developing a “multi-modal, contextual experience” that extends its AI beyond simply “picking up the phone.” Parloa sees abundant room for multiple winners in the space and believes its capitalization gives it an edge over rivals such as Sierra, Decagon, PolyAI, Intercom, and Kore.ai. Its rapid growth is underscored by a valuation jump from $1 billion to $3 billion in just eight months. The business is already enterprise-ready, with agents answering live calls for global customers today.

Participated · Equity · Jan 2026

VieCure provides Halo Intelligence™, an artificial-intelligence–driven platform that combines structured patient data, a clinical inference engine, and workflow automation to assist oncologists in selecting evidence-based, personalized cancer treatments. Designed as both a smart EMR and real-time decision-support tool, Halo helps reduce clinical complexity, increase guideline-compliant care, and boost practice efficiency. The system is currently used to manage care for nearly 30,000 patients across a growing national network of community oncology locations. Reported outcomes include an approximately eight-fold increase in tumor sequencing rates, a two-fold rise in guideline-aligned treatment plans, and measurable gains in oncologist capacity and workflow productivity. VieCure partners with cancer centers and life-science organizations throughout the United States. Proceeds from its latest financing will be used to expand product capabilities and accelerate market penetration among community oncology practices. Board additions and operational support from investor Mitch Rales’ New Bearing firm aim to instill world-class operating discipline as the company scales.